Valproic Acid Restores ERα and Antiestrogen Sensitivity to ERα-negative Breast Cancer Cells

Molecular and Cellular Endocrinology - Ireland
doi 10.1016/j.mce.2009.09.011
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Erratum To: MGMT Inhibition Restores ERα Functional Sensitivity to Antiestrogen Therapy

Molecular Medicine
Molecular MedicineGeneticsMolecular Biology
2012English

Curcumin Restores Sensitivity to Retinoic Acid in Triple Negative Breast Cancer Cells

BMC Cancer
Cancer ResearchOncologyGenetics
2014English

Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2019English

MiR-190b, the Highest Up-Regulated miRNA in ERα-positive Compared to ERα-negative Breast Tumors, a New Biomarker in Breast Cancers?

BMC Cancer
Cancer ResearchOncologyGenetics
2015English

Cystatin SN Affects Cell Proliferation by Regulating the ERα/PI3K/AKT/ERα Loopback Pathway in Breast Cancer

OncoTargets and Therapy
OncologyPharmacology
2019English

Interfering Role of ERα on Adiponectin Action in Breast Cancer

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2020English

FOXK2 Transcription Factor Suppresses ERα-positive Breast Cancer Cell Growth Through Down-Regulating the Stability of ERα via Mechanism Involving BRCA1/BARD1

Scientific Reports
Multidisciplinary
2015English

A Bi-Stable Feedback Loop Between GDNF, EGR1, and ERα Contribute to Endocrine Resistant Breast Cancer

PLoS ONE
Multidisciplinary
2018English

Progression of Mouse Skin Carcinogenesis Is Associated With Increased Erα Levels and Is Repressed by a Dominant Negative Form of Erα

PLoS ONE
Multidisciplinary
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy